Heart diseases are a growing concern in India. If the current trend continues, cardiovascular diseases in India will surpass any other country in the world. Heart diseases are the world's leading cause of death.
Systopic as a corporate is committed to provide best possible value to the patients through our fair pricing policy in this chronic segment. We introduced Amlodipine, the first Calcium Channel blocker in India way back in 1991 and Amace, the first combination of CCB with an ACE inhibitor. Over the years, we have developed several products that help treat various diseases like MI, angina, heart failure, hypertension, lipid abnormalities and diabetes.
Apart from innovation in cardiology, we also provide valuable services to the medical fraternity, in the form of the latest medical updates.In the coming years, we shall continue to introduce novel drugs and combinations.Know More